Response to Office Action

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1957 (Rev 10/2011)

OMB No. 0651-0050 (Exp 09/20/2020)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1957 (Rev 10/2011)

OMB No. 0651-0050 (Exp 09/20/2020)

Response to Office Action

To the Commissioner for Trademarks:

Application serial no. 88323300 MEDZINO(Standard Characters, see http://uspto.report/TM/88323300/mark.png) has been amended as follows:

CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 005 for Contraceptive foams; Contraceptive preparations; Contraceptive sponges; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of Hair loss, erectile dysfunction, genital herpes, genital warts, yeast infections, acne, rosacea, headaches, asthma, high blood pressure, high cholesterol, birth control, acid reflux, smoking, cold sores, premature ejaculation, bacterial vaginosis, cystitis/UTI, HRT; Pharmaceutical preparations for the treatment of Hair loss, erectile dysfunction, genital herpes, genital warts, yeast infections, acne, rosacea, headaches, asthma, high blood pressure, high cholesterol, birth control, acid reflux, smoking, cold sores, premature ejaculation, bacterial vaginosis, cystitis/UTI, HRT; Chemical contraceptives; Natural supplements for treating erectile dysfunction; Oral contraceptives; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceuticals for the treatment of erectile dysfunction
Original Filing Basis:
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

Proposed:
Tracked Text Description: Contraceptive foams; Contraceptive preparations; Contraceptive sponges; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of Hair loss, erectile dysfunction, genital herpes, genital warts, yeast infections, acne, rosacea, headaches, asthma, high blood pressure, high cholesterol, birth control, acid reflux, smoking, cold sores, premature ejaculation, bacterial vaginosis, cystitis/UTI, HRT; Pharmaceutical preparations for the prevention of Hair loss, erectile dysfunction, genital herpes, genital warts, yeast infections, acne, rosacea, headaches, asthma, high blood pressure, high cholesterol, birth control, acid reflux, smoking, cold sores, premature ejaculation, bacterial vaginosis, cystitis, urinary tract infections, and hormone replacement therapy; Pharmaceutical preparations for the treatment of Hair loss, erectile dysfunction, genital herpes, genital warts, yeast infections, acne, rosacea, headaches, asthma, high blood pressure, high cholesterol, birth control, acid reflux, smoking, cold sores, premature ejaculation, bacterial vaginosis, cystitis/UTI, HRT; Pharmaceutical preparations for the treatment of Hair loss, erectile dysfunction, genital herpes, genital warts, yeast infections, acne, rosacea, headaches, asthma, high blood pressure, high cholesterol, birth control, acid reflux, smoking, cold sores, premature ejaculation, bacterial vaginosis, cystitis, urinary tract infections, and hormone replacement therapy; Chemical contraceptives; Natural supplements for treating erectile dysfunction; Oral contraceptives; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceuticals for the treatment of erectile dysfunctionClass 005 for Contraceptive foams; Contraceptive preparations; Contraceptive sponges; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of Hair loss, erectile dysfunction, genital herpes, genital warts, yeast infections, acne, rosacea, headaches, asthma, high blood pressure, high cholesterol, birth control, acid reflux, smoking, cold sores, premature ejaculation, bacterial vaginosis, cystitis, urinary tract infections, and hormone replacement therapy; Pharmaceutical preparations for the treatment of Hair loss, erectile dysfunction, genital herpes, genital warts, yeast infections, acne, rosacea, headaches, asthma, high blood pressure, high cholesterol, birth control, acid reflux, smoking, cold sores, premature ejaculation, bacterial vaginosis, cystitis, urinary tract infections, and hormone replacement therapy; Chemical contraceptives; Natural supplements for treating erectile dysfunction; Oral contraceptives; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceuticals for the treatment of erectile dysfunction
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

APPLICANT AND/OR ENTITY INFORMATION
Applicant proposes to amend the following:
Current: Medzino Healthcare, Inc., DBA Medzino, a corporation of Delaware, having an address of
      16192 Coastal Highway
      Lewes, Delaware 19958
      United States

      XXXX (authorized)
      +44-7739638465
Proposed: Medzino Health, Inc., DBA Medzino, a corporation of Delaware, having an address of
      16192 Coastal Highway
      Lewes, Delaware 19958
      United States
      XXXX (authorized)
      +44-7739638465

SIGNATURE(S)
Response Signature
Signature: /js/     Date: 05/13/2019
Signatory's Name: Jeff Stoller
Signatory's Position: Attorney, California Bar member

Signatory's Phone Number: 305-725-1302

The signatory has confirmed that he/she is an attorney who is a member in good standing of the bar of the highest court of a U.S. state, which includes the District of Columbia, Puerto Rico, and other federal territories and possessions; and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S. attorney or a Canadian attorney/agent not currently associated with his/her company/firm previously represented the owner/holder in this matter: (1) the owner/holder has filed or is concurrently filing a signed revocation of or substitute power of attorney with the USPTO; (2) the USPTO has granted the request of the prior representative to withdraw; (3) the owner/holder has filed a power of attorney appointing him/her in this matter; or (4) the owner's/holder's appointed U.S. attorney or Canadian attorney/agent has filed a power of attorney appointing him/her as an associate attorney in this matter.

        
Serial Number: 88323300
Internet Transmission Date: Mon May 13 18:34:47 EDT 2019
TEAS Stamp: USPTO/ROA-XX.XXX.XX.XXX-2019051318344753
0932-88323300-6202d259e5dcd2faa58cd4bb14
70c0ab462a98540b74c989bb1b0d6611f182a-N/
A-N/A-20190513182833271713